IMR Press / CEOG / Volume 40 / Issue 3 / pii/1630388293528-632399049

Clinical and Experimental Obstetrics & Gynecology (CEOG) is published by IMR Press from Volume 47 Issue 1 (2020). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.

Original Research
Idiopathic premature ovarian failure: what is the most suitable ovarian stimulation protocol?
Show Less
1 Reproductive Endocrinology and Infertility, American University of Beirut Medical Center, Beirut
2 Cytogenetics, American University of Beirut Medical Center, Beirut
3 Reproductive Endocrinology and Infertility, Rizk Hospital, Beirut (Lebanon)
4 Reproductive Endocrinology and Infertility, Harvard Medical School, Boston, MA (USA)
Clin. Exp. Obstet. Gynecol. 2013, 40(3), 327–330;
Published: 10 September 2013
Abstract

Objective: To evaluate the ovarian response to ovarian stimulation in women with idiopathic premature ovarian failure (POF) in a prospective, controlled, and sequential crossover pilot study. Materials and Methods: Ten women with idiopathic premature ovarian failure and normal karyotype were included in the study. Phase I was comprised of three consecutive control cycles consisting each of estrogen progestin sequential therapy. Phase II was comprised of three consecutive treatment cycles combining the use of gonadotropin-releasing hormone agonist (GnRHa) in the background of estrogen priming, followed by gonadotropin ovarian stimulation and corticosteroid immunosuppression. Results: Ovulation rates in the treatment cycles (0/10; 0%) did not differ from control cycles (0/10; 0%). Conclusions: The findings of this pilot study showed that the combination of estrogen priming, corticosteroid immune-suppression, GnRHa pituitary desensitization, and followed by gonadotropin ovarian stimulation is ineffective in restoring ovarian function in women with idiopathic POF.
Keywords
Premature ovarian failure
Ovarian stimulation
Gonadotropins
Corticosteroids
Gonadotropin-releasing hormone agonist
Estrogen replacement
Share
Back to top